Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OmnicellMEX:OMCL 76 EBIT per Share is MXN22.30 as of Jun. 2026. GuruFocus rates MEX:OMCL with a GF Score™ of 76/100 and a GF Value™ of MXN810.42. The stock has 6 warning signs investors should review. Among 523 Healthcare Providers & Services companies, Omnicell ranks worse than 191204.4% on this metric.
Omnicell's EBIT per Share for the
three
months ended in Jun. 2026 was MXN12.23.
Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2026 was MXN22.30.
During the past 12 months, the average EBIT per Share Growth Rate of Omnicell was 283.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Omnicell's EBIT per Share or its related term are showing as below:
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Omnicell was 133.90% per year. The lowest was -84.50% per year. And the median was 11.70% per year.
MEX:OMCL's 3-Year EBIT Growth Rate is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 11.9 * Ranked among companies with meaningful 3-Year EBIT Growth Rate only.
Omnicell's EBIT for the
three
months ended in Jun. 2026 was MXN566 Mil.
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Omnicell EBIT per Share Related Terms
Omnicell EBIT per Share Historical Data
* Premium members only.
The historical data trend for Omnicell's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN22.30
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Omnicell (MEX:OMCL) has a EBIT per Share of MXN22.30 as of Jun. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Omnicell and its competitors. According to the industry distribution chart, Omnicell ranks #999999 out of 523 companies in the Healthcare Providers & Services industry.
Is Omnicell's EBIT per Share too high?
Omnicell's current EBIT per Share is MXN22.30. Based on the distribution chart, Omnicell ranks #999999 out of 523 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Omnicell has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Omnicell's EBIT per Share compare to HTFL and TDOC?
According to the Healthcare Providers & Services industry distribution chart, Omnicell ranks #999999 out of 523 companies for EBIT per Share. This places Omnicell in the lower half of its industry. The industry median EBIT per Share is 11.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 11.90, based on 523 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Omnicell and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 11.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Omnicell's current EBIT per Share is MXN22.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omnicell stock overvalued right now?
Omnicell (MEX:OMCL) has a current EBIT per Share of MXN22.30. The stock's GF Value™ is MXN810.42, compared to a current price of MXN761.16 — trading 6.1% below its estimated fair value. The current EBIT per Share is MXN22.30. Omnicell's overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Omnicell (MEX:OMCL), the current EBIT per Share is MXN22.30 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Omnicell (MEX:OMCL) Overvalued in 2026?
Based on GuruFocus' analysis, Omnicell stock appears to be undervalued.
The current stock price of MXN761.16 is trading 6.1% below its estimated GF Value™ of MXN810.42.
Key valuation signals for MEX:OMCL:
EBIT per Share: MXN22.30
GF Value™: MXN810.42 vs. price of MXN761.16 (6.1% below fair value)
No single metric tells the full story. See the MEX:OMCL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
76GF Score
Get the complete analysis for MEX:OMCL
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:OMCL has been successfully added to your 
